Major Merger in Cancer Care: MOC and HOC Join Forces
Mumbai Oncocare and Gujarat Hemato Oncology Clinic-Vedanta are merging to create a new entity, expanding their reach with 22 community cancer care centres in Maharashtra, Madhya Pradesh, and Gujarat. This merger will enhance access to advanced cancer treatments, impacting over 22,000 lives and administering 60,000 chemotherapies annually. The expansion is supported by a USD 10 million investment from Tata Capital Healthcare Fund.
- Country:
- India
Mumbai Oncocare (MOC) Cancer Care and Research Centre and Gujarat Hemato Oncology Clinic-Vedanta (HOC) have announced a significant merger, aimed at transforming cancer treatment in Western India.
The combined entity will span 22 community cancer care centres across Maharashtra, Madhya Pradesh, and Gujarat, emphasizing accessibility and advanced treatment options.
This strategic move, supported by a USD 10 million investment from the Tata Capital Healthcare Fund, is projected to impact over 22,000 lives and facilitate more than 60,000 annual chemotherapies.
ALSO READ
-
Nuclear Science Brings Cancer Care, Safer Food and Better Water Data Across Regions
-
From Cancer Care to Nuclear Careers, IAEA Conference Puts Global Progress in Focus
-
IAEA and IDB Join Forces to Expand Nuclear Energy in Latin America and Caribbean
-
IAEA Joins Forces With Six Industry Partners to Close Global Cancer Care Divide
-
IAEA’s Rays of Hope Raises Over €100 Million to Bring Cancer Care Within Reach
Google News